GlassScriptPhysician profile
Cynthia Alessio
NPI 1922457589
$4,772.05
in general payments reported to CMS, 2019-2025
23 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.55 · 2020: $34.17 · 2021: $3,826 · 2022: $332 · 2023: $353 · 2024: $102 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,018.14 | 2021-2025 | |
| Abbvie INC. | $465.79 | 2019-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $313.90 | 2021-2025 | Coolseal Generator, Acessa Provu System, Aptima |
| Aspira Women'S Health INC | $288.29 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $100.57 | 2023-2024 | Gemtesa |
| Urovant Sciences INC | $95.72 | 2022 | |
| Baxter Healthcare | $84.65 | 2021 | |
| Mylan Pharmaceuticals INC. | $84.31 | 2021-2022 | |
| Astellas Pharma US INC | $58.22 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $44.61 | 2021 | |
| Exeltis, USA INC. | $26.55 | 2021 | |
| Lupin INC. | $22.75 | 2021 | |
| Medicem INC. | $18.08 | 2020 | |
| Myovant Sciences INC. | $17.49 | 2021 | |
| Daiichi Sankyo INC. | $17.24 | 2024 | Injectafer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $16.44 | 2022 | |
| Shield Therapeutics INC | $14.90 | 2022 | |
| Millicent US INC | $14.81 | 2025 | Femring, Intrarosa |
| Becton, Dickinson and Company | $14.61 | 2025 | Arista |
| Smith+Nephew, INC. | $14.10 | 2025 | Stravix |
| Coopersurgical, INC. | $13.97 | 2024 | Paragard T 380a |
| Agile Therapeutics, INC. | $13.48 | 2021 | |
| Organon LLC | $13.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Alessio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.